Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Shareholder Meeting (November 2022)
12 slides from Mach7 Technologies's shareholder meeting presentation, Nov 17, 2022
Slide 1: Mach7 Annual General Meeting
For personal use only Mach7 Annual General Meeting 17 November 2022 PRESENTATION
Slide 2: Disclaimer "forward looking" statements
Disclaimer “forward looking” statements For personal use only Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities c
Slide 3: CEO Presentation
(“Corporation CEO Presentation For personal use only Mr. Mike Lampron Issued 18 February 2021, approved by the Board 7 7
Slide 4: CEO Presentation – 2022 AGM: Business Overview
CEO Presentation – 2022 AGM For personal use only Business Overview • Our Business • Our Market • Our Products • Our Global Footprint • Our Differentiators • Our FY22 Highlights • Our FY23 Focus • Outlook 4
Slide 5: Our Business
Our Business Mach7 – The Enterprise Imaging Solution For personal use only Mach7’s medical imaging software solution centralises, stores, organises and displays patient data across the healthcare enterprise – connecting hospital networks and facilitating data flow between hospital departments and cl
Slide 6: Our Market
Our Market For personal use only Enterprise Imaging is a strategy rather than a product Enterprise imaging refers to the ability to store and/or view medical images across the healthcare enterprise from more than one service line or department. Enterprise Imaging Picture Archive Vendor Neutral Archi
Slide 7: Our Products
Our Products Enterprise Imaging – a focus on the entire healthcare network For personal use only Mach7 provides an enterprise-wide interoperable platform for storing, retrieving and viewing all medical imaging data in one vendor neutral ecosystem. It comprises: Enterprise Data Management Enterprise
Slide 8: Our Global Footprint
Our Global Footprint For personal use only >150 Customers 15 Countries Australia Canada China France Hong Kong Indonesia Italy Netherlands Qatar Philippines Singapore Saudi Arabia Hospital United Kingdom systems around United States the world use Mach7 Vietnam Technologies = Primary Markets = Global
Slide 9: Our Differentiators
Our Differentiators For personal use only • Enterprise First Strategy • Top Product Rankings • VNA backend data management solution • Mach7’s VNA ranked #3 and Viewer ranked #2 by designed and built for entire healthcare independent customer survey network rather than the radiology department • Zero
Slide 10: Our FY22 Highlights
Our FY22 Highlights For personal use only Annual Recurring Record Sales Order Contracted Annual Revenue (ARR) growth (TCV)1 Record Revenue Recurring $13.4M recognised $33.2M $27.1M Revenue (CARR) +$2.5M or 23% PCP +$7.6M or 30% PCP2 +$8.1M or 42% PCP $17.3M $14.4M run rate +$1.5M or 9.5% PCP +$1M or
Slide 11: Our FY23 Focus
Our FY23 Focus For personal use only Sales/Partnerships Investment Cashflow New Sales and New Partnerships Engineering Excellence Remain Cashflow Positive Sales effort on New Engineering hiring phase Cash receipts to be customers and increasing near complete - attrition boosted by staggered book of
Slide 12: Outlook
Outlook For personal use only Industry Product Sales & Marketing Financial Growing trend for Highly acclaimed APAC region to make Targeting FY23 sales orders hospitals to outsource products translating to greater contribution to sales of at least $36M (+8% on non-urgent radiology. marketplace orders
Mach7 Technologies — Shareholder Meeting (November 2022) on 6ix